| Literature DB >> 31139362 |
Dorothea Orth-Höller1, Reinhard Würzner1, Martina Prelog2, Peninnah Oberdorfer3, Benjamin Hetzer4, Peter Kreidl1, Michaela Lackner1, Thomas Müller4, Ludwig Knabl1, Daniel Rudolf Geisler-Moroder1, Alexander Mellmann5, Özcan Sesli1, Jeanett Holzknecht1, Damia Noce6, Orawan Boonpala3, Noppadon Akarathum7, Somporn Chotinaruemol3.
Abstract
Background: Increasing bacterial resistance to antibiotics is a serious problem worldwide. We sought to record the acquisition of antibiotic-resistant Escherichia coli (E. coli) in healthy infants in Northern Thailand and investigated potential determinants.Entities:
Keywords: Antibiotic resistance; Children; Escherichia coli; Multiresistance; Neonates; Persistence; Transmission
Mesh:
Substances:
Year: 2019 PMID: 31139362 PMCID: PMC6528363 DOI: 10.1186/s13756-019-0522-6
Source DB: PubMed Journal: Antimicrob Resist Infect Control ISSN: 2047-2994 Impact factor: 4.887
Demographic characteristics of study participants (n = 142)
| Number | Proportion (%) | |
|---|---|---|
| Gender | ||
| Males | 75 | 52.8 |
| Females | 67 | 47.2 |
| Week of gestation | ||
| Preterms (<37wk) | 20 | 14.1 |
| Birth mode | ||
| Vaginal | 110 | 77.5 |
| Caesarean-section | 32 | 22.5 |
| Birth complication of newborn | ||
| Yes | 8 | 5.6 |
| Hospital | ||
| Tertiary urban hospital | 90 | 63.4 |
| Urban birth clinic | 31 | 21.8 |
| Rural hospital | 21 | 14.8 |
| Antibiotic usage during pregnancy | ||
| Yes | 30 | 21.1 |
| Siblings | ||
| Yes | 57 | 42.5 |
| Pets | ||
| Yes | 67 | 47.2 |
| Exclusively breast feeding at | ||
| 48 h | 95 | 66.9 |
| 2wk | 109 | 76.8 |
| 2 m | 106 | 74.6 |
| 4-6 m | 77 | 54.2 |
| 1y | 0 | 0 |
| Antibiotic usage during 1y | ||
| < 48 h | 9 | 6.3 |
| < 2wk | 13 | 9.2 |
| < 2 m | 21 | 14.7 |
| < 4-6 m | 29 | 20.4 |
| 1y | 54 | 38.0 |
| First appearance of AB resistant | ||
| Meconium | 49 | 34.5 |
| < 2wk | 89 | 62.7 |
| < 2 m | 113 | 79.6 |
| < 4-6 m | 132 | 93.0 |
| 1y | 142 | 100.0 |
Fig. 1Flowchart of stool sample collection over the one- year study period. Initially 169 families were included. 27 were excluded due to exclusion criteria (> 1 missing stool sample) or loss of follow-up
Fig. 2Prevalence of carriage of resistant E. coli resistant to tetracycline (TET), ampicillin (AM), co- trimoxazole (SXT), and cefazoline (CEF) in fathers, mothers, meconium of newborns, and infants at 2wk, 2mo, 4 - 6mo, and 1y
Numbers (n) of samples containing resistant E. coli and numbers of detected resistant E. coli strains in parents and infants during the first year of life
| Population | Follow-Up Event | n samples | n samples containing resistant | n detected resistant | CN (%) | SXT (%) | AM (%) | FM (%) | TMP (%) | GM (%) | FOT (%) | ETP (%) | AMC (%) | CXM (%) | CPD (%) | MEC (%) | FOX (%) | CIP (%) | TZP (%) | CRO (%) | TET (%) | CEF (%) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Fathers | 48 h | 140 | 131 (94) | 295 | 24% | 70% | 84% | 6% | 71% | 25% | 1% | 0 (0) | 6% | 33% | 26% | 7% | 6% | 33% | 1% | 17% | 87% | 37% |
| Mothers | 48 h | 142 | 135 (95) | 263 | 13% | 62% | 87% | 5% | 62% | 17% | 0 (0) | 0 (0) | 3% | 18% | 16% | 3% | 2% | 24% | 0% | 12% | 87% | 29% |
| Infants | 48 h | 142 | 47 (33) | 65 | 4% | 20% | 25% | 1% | 19% | 7% | 0 (0) | 0 (0) | 1% | 4% | 3% | 2% | 3% | 6% | 0% | 3% | 30% | 8% |
| Infants | 2wk | 138 | 70 (51) | 71 | 7% | 24% | 33% | 1% | 30% | 5% | 0 (0) | 0 (0) | 1% | 7% | 7% | 4% | 1% | 10% | 0% | 5% | 39% | 13% |
| Infants | 2mo | 142 | 84 (59) | 99 | 8% | 39% | 49% | 1% | 39% | 7% | 1% | 0 (0) | 4% | 7% | 6% | 8% | 1% | 8% | 0% | 5% | 46% | 12% |
| Infants | 4-6mo | 134 | 111 (83) | 198 | 13% | 45% | 72% | 3% | 50% | 16% | 3% | 0 (0) | 7% | 12% | 10% | 7% | 4% | 18% | 0% | 7% | 65% | 22% |
| Infants | 1y | 142 | 131 (92) | 232 | 18% | 66% | 72% | 1% | 65% | 27% | 1% | 0 (0) | 8% | 17% | 18% | 9% | 2% | 27% | 3% | 13% | 80% | 35% |
Fig. 3Overview of single-resistance (R1) or multi-resistance (R2-R11) patterns of collected E. coli strains in parents (a) and infants (b). The most prevalent resistance pattern is illustrated in black, the next most in light grey, and others in dark grey. (tested antibiotics: AM, ampicillin; AMC, amoxicillin-clavulanic acid; CIP, ciprofloxacin; CN, cefalexin; CPD, cefpodoxime; CRO, ceftriaxone; CXM, cefuroxime; ETP, ertapenem; FM, nitrofurantoin; FOS, fosfomycin; GM, gentamcin; MEC, mecillinam; SXT, co-trimoxazole; TET, tetracycline; TMP, trimethoprim; TZP, piperacillin-tazobactam)
Fig. 4Minimum-spanning tree of the 19 transmitted and persistent (yellow), persistent (orange), transmitted (red), and control strains based on allelic profiles of the respective MLST ST. Each dot represents an allelic profile and the numbers on connecting lines display the number of differing alleles in a pairwise comparison. The dots are named with the isolate IDs and colored according to their assumed epidemiology / origin
Univariate analysis of determinants associated with prevalence of resistant E. coli in meconium